Advances in platform technologies are transforming the way innovative and personalised medicines, including advanced therapies, can be developed and scaled. At conect4children Stichting we are committed to improving healthcare outcomes for children, and we closely follow developments that may accelerate safe, effective, and equitable access to future treatments.
The European Medicines Agency (EMA) is hosting a public webinar on 2 March 2026 (09:25–12:15 CET) focused on the regulatory use of platform technologies in both non-clinical and clinical domains.
Pharmaceutical platform technologies are foundational, reusable systems—such as mRNA, viral vectors, AI-driven molecular screening, and lipid nanoparticles—used to develop multiple drugs or vaccines faster and more efficiently. These platforms reduce reliance on starting from scratch, allowing for rapid adaptation to new diseases and improving delivery, targeting, and safety.
The session will cover:
🔹 How EU rules support individualised (n=1) therapies
🔹 Real-world non-clinical & clinical case studies
🔹 Opportunities and challenges for industry, biotech & academia
🔹 Future roles of platform technologies in medicine development
No registration is required. You can join the live session via the link available on the EMA event page.
🔗 Webinar on the use of platform technologies in the non-clinical and clinical domains | European Medicines Agency (EMA)
We are sharing this information for those across our network who may be interested in how platform-based innovation could shape the future of medicine development, including its potential impact on paediatric care.
Cookie policy